CISPLATIN THERAPY FOR DISSEMINATED MIXED MESODERMAL SARCOMA OF THE UTERUS

被引：35

作者：

GERSHENSON, DM ^{[1
]}

KAVANAGH, JJ ^{[1
]}

COPELAND, LJ ^{[1
]}

EDWARDS, CL ^{[1
]}

STRINGER, CA ^{[1
]}

WHARTON, JT ^{[1
]}

机构：

[1] UNIV S FLORIDA,H LEE MOFFITT CANC CTR & RES INST,TAMPA,FL 33620

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1987年 / 5卷 / 04期

关键词：

D O I：

10.1200/JCO.1987.5.4.618

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：618 / 621

页数：4

共 13 条

[1]

BADIB AO, 1969, CANCER-AM CANCER SOC, V24, P724, DOI 10.1002/1097-0142(196910)24:4<724::AID-CNCR2820240410>3.0.CO

[2]

2-D

[3] SURVIVAL CURVE FOR CANCER PATIENTS FOLLOWING TREATMENT [J].

BERKSON, J ;

GAGE, RP .

JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1952, 47 (259) :501-515

[4] MIXED MESODERMAL SARCOMA OF UTERUS [J].

DISAIA, PJ ;

CASTRO, JR ;

RUTLEDGE, FN .

AMERICAN JOURNAL OF ROENTGENOLOGY, 1973, 117 (03) :632-636

[5] ADJUVANT CHEMOTHERAPY IN EARLY UTERINE SARCOMA [J].

HANNIGAN, EV ;

FREEDMAN, RS ;

RUTLEDGE, FN .

GYNECOLOGIC ONCOLOGY, 1983, 15 (01) :56-64

[6] TREATMENT OF ADVANCED UTERINE SARCOMA WITH ADRIAMYCIN [J].

HANNIGAN, EV ;

FREEDMAN, RS ;

ELDER, KW ;

RUTLEDGE, FN .

GYNECOLOGIC ONCOLOGY, 1983, 16 (01) :101-104

[7] PROGNOSTIC FACTORS IN MALIGNANT MESODERMAL (MULLERIAN) MIXED TUMORS OF THE UTERUS [J].

MACASAET, MA ;

WAXMAN, M ;

FRUCHTER, RG ;

BOYCE, J ;

HONG, P ;

NICASTRI, AD ;

REMY, JC .

GYNECOLOGIC ONCOLOGY, 1985, 20 (01) :32-42

[8]

SALAZAR OM, 1978, CANCER-AM CANCER SOC, V42, P1152, DOI 10.1002/1097-0142(197809)42:3<1152::AID-CNCR2820420319>3.0.CO

[9]

2-L

[10]

SELTZER V, 1984, CANCER TREAT REP, V68, P1389

← 1 2 →